Loss of SUZ12 promotes the onset of a variety of malignancies, including blood cancer subtypes (De Raedt et al., 2014; Ntziachristos et al., 2012; AACR Project GENIE Consortium, 2017). This evidence concerns the gene SUZ12 and hematopoietic and lymphoid system neoplasm.